Physician profile
Gillian Stuart
NPI 1720143696
$904.80
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $11.03 · 2021: $28.05 · 2022: $26.99 · 2023: $271 · 2024: $85.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $482.68 | 2019 | |
| Davol INC. | $191.95 | 2021-2023 | Channel Drain, Phasix Mesh |
| Stryker Corporation | $65.72 | 2023 | 1688, Spy-Phi System |
| Integra Lifesciences Corporation | $33.74 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $26.99 | 2022 | |
| Kci USA, INC. | $25.03 | 2020-2021 | |
| Smith+Nephew, INC. | $22.22 | 2024 | Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $15.49 | 2024 | Nuzyra |
| Microline Surgical INC | $14.20 | 2023 | |
| Convatec INC. | $13.78 | 2024 | |
| Boston Scientific Corporation | $13.00 | 2023 | Spyglass |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gillian Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.